Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 2 16:15 ET
Vir Biotechnology | DEFA14A: Others
Apr 19 08:38 ET
Vir Biotechnology | DEF 14A: Definitive information statements
Apr 19 08:33 ET
Vir Biotechnology | 8-K: Current report
Apr 18 08:46 ET
Vir Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 26 16:31 ET
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 22 16:24 ET
Vir Biotechnology | 8-K: Current report
Feb 20 16:45 ET
Vir Biotechnology | 8-K: Current report
Dec 13, 2023 16:06 ET
Vir Biotechnology | 8-K: Current report
Nov 3, 2023 16:37 ET
Vir Biotechnology | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Nov 3, 2023 16:33 ET
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Nov 2, 2023 16:09 ET
Vir Biotechnology | 8-K: Current report
Oct 3, 2023 08:01 ET
Vir Biotechnology | 8-K: Current report
Sep 20, 2023 06:02 ET
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Aug 3, 2023 16:14 ET
Vir Biotechnology | 8-K: Current report
Jul 20, 2023 08:04 ET
Vir Biotechnology | 8-K: Current report
May 23, 2023 16:06 ET
Vir Biotechnology | 8-K: Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 4, 2023 16:16 ET
Vir Biotechnology | DEFA14A: Others
Apr 7, 2023 16:09 ET
Vir Biotechnology | DEF 14A: Definitive proxy statements
Apr 7, 2023 16:07 ET
Vir Biotechnology | 8-K: Current report
Mar 10, 2023 21:45 ET
No Data
No Data